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Abstract
Olefin metathesis is one of the most powerful C–C double-bond-forming reactions. Metathesis reactions have had a tremendous
impact in organic synthesis, enabling a variety of applications in polymer chemistry, drug discovery and chemical biology. Al-
though challenging, the possibility to perform aqueous metatheses has become an attractive alternative, not only because water is a
more sustainable medium, but also to exploit biocompatible conditions. This review focuses on the progress made in aqueous olefin
metatheses and their applications in chemical biology.
Introduction
Olefin metathesis represents a versatile synthetic tool for the
construction of carbon–carbon bonds [1-9]. Since its first report
in 1956, a Ti(II)-catalyzed polymerization of norbornene [10],
metathesis rapidly attracted interest among organic chemists
and has been used in different research fields spanning polymer
chemistry [11,12] to drug discovery [13-15]. Scheme 1 displays
the most common metathesis reactions.
The metathesis reaction mechanism, proposed by Chauvin in
1971, suggests that the reaction proceeds via the reversible for-
mation of a metallacyclobutane intermediate (Scheme 2, inter-
mediates II and IV) [16]. The catalytic cycle involves an initial
[2 + 2] cycloaddition between a metal carbene I and an olefin,
followed by a retro [2 + 2] cycloaddition, leading to the release
of a “scrambled” olefin (e.g., ethylene in Scheme 2) and the
metal carbene species III as key intermediate. A [2 + 2] cyclo-
addition with a second olefin leads to the formation of interme-
diate IV, followed by a retro [2 + 2] cycloaddition that regener-
ates catalyst I and releases the metathesis product. This
visionary mechanistic proposal was later confirmed by experi-
mental studies [17-20].
Ruthenium-based catalysts are among the most tolerant and
stable metathesis catalysts and are widely employed for metath-
Beilstein J. Org. Chem. 2019, 15, 445–468.
446
Scheme 1: Most common metathesis reactions. Ring-opening metath-
esis polymerization (ROMP), acyclic diene metathesis (ADMET), ring-
closing metathesis (RCM), ring-opening metathesis (ROM), and cross-
metathesis (CM).
Scheme 2: Catalytic cycle for metathesis proposed by Chauvin.
eses in aqueous media [21,22]. There is a growing interest in
performing metathesis reactions in water as a greener alterna-
tive to chlorinated or aromatic solvents [23,24]. Water is inex-
pensive, non-flammable, non-toxic and environmentally
friendly, all characteristics that make it an ideal solvent.
Furthermore, water is the media of biochemical reactions, and
metathesis is a bioorthogonal reaction that can be exploited in a
biological setting. Figure 1 illustrates some of the most repre-
sentative catalysts developed for aqueous metathesis. Water-
soluble catalysts are obtained by derivatization of classical cata-
lysts G-II and HG-II (Figure 1a), resulting from the introduc-
tion of ionic tags and highly polar groups such as ammonium
tags (Figure 1b) and PEGs (Figure 1c). This review focuses on
the recent improvements of olefin metathesis in aqueous media
and the resulting applications in bioinorganic chemistry and
chemical biology.
Review
Challenges in aqueous metathesis
The first examples of aqueous metathesis were reported in the
late 1980s [25,26]. ROMP reactions of 7-oxanorbornene deriva-
tives 13 and 14 were carried out with the so-called “ill-defined”
catalysts, namely RuCl3·H2O and Ru(OTs)2(H2O)6 [27,28]
(Scheme 3). However, these catalysts had limited usefulness
due to a slow initiation rate and detrimental effect of water on
the reaction mixture.
Water can lead to the formation of catalytically inactive Ru
hydride species. Fürstner et al. isolated these complexes as by-
products during the synthesis of Grubbs second generation-type
catalysts with saturated NHC ligands [29]. In this specific case,
the formation of the metal hydride complex is believed to occur
during the work-up with methanol. Dinger and Mol also carried
out studies supporting this theory [30]. In their report, they
elucidated the degradation pathway of the first generation
Grubbs catalyst (G-I) in the presence of primary alcohols
and water (Scheme 4). The detrimental effect of water is more
likely to occur at high temperatures and in the presence of a
base.
1H NMR studies revealed that methanol is the source of hydride
and this was later confirmed by Grubbs and co-workers [31].
The proposed mechanism for the degradation of G-I occurs via
alcohol dehydrogenation followed by decarbonylation of the ru-
thenium hydride 16.
In 2015, Cazin and co-workers showed that the detrimental
effect of H2O also occurs with the more innovative catalysts
Caz-I, Ind-II and HG-II (Table 1) [32]. The authors per-
formed the RCM of the challenging substrate 17 in toluene at
110 °C, reporting excellent yields in reactions carried out on a
benchtop under air using non-degassed technical-grade sol-
vents. However, upon addition of 100 µL of distilled degassed
water to the reaction mixture, the conversions dropped to 36%,
15% and 8%, respectively, for HG-II, Caz-I, and Ind-II
(Table 1). Thus, the presence of H2O (ca. 6%) severely affects
the phosphine-based catalysts Caz-I and Ind-II, while it has a
less pronounced detrimental effect on the isopropyloxy-benzyl-
idene catalyst HG-II.
“On water” vs “in water” metathesis
Hydrophobic catalysts are able to perform metathesis in
aqueous mixtures. Blechert and Raines reported examples of
RCM, CM and ROMP in heterogeneous conditions with hydro-
phobic catalysts [21,33]. Blechert prepared alkoxy- and cyano-
substituted catalysts 19 and 20 from G-II (Scheme 5) [34],
while Raines and co-workers employed the conventional cata-
lysts G-II and HG-II [35].
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Figure 1: Some of the most representative catalysts for aqueous metathesis. a) Well-defined ruthenium catalysts. b) Catalysts bearing ammonium
tags. c) PEG-tethered catalysts.
Blechert and Raines both performed RCM reactions with the
benchmark substrate 21 in mixtures of water/organic solvent at
room temperature in air (Table 2).
Table 2 summarizes the activities of the different ruthenium
catalysts in protic media. The ratio water/co-solvent affects the
RCM of substrate 21 catalyzed by G-II (77% conversion in
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Scheme 3: First aqueous ROMP reactions catalyzed by ruthenium(III) salts.
Scheme 4: Degradation pathway of first generation Grubbs catalyst (G-I) in methanol.
Table 1: RCM of challenging substrate 17 in air and in the presence of water.
Ru cat. dry air (conv. %) air (conv. %) H2O (conv. %)
Caz-I 90 60 15
Ind-II 70 22 8
HG-II 60 38 36
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Scheme 5: Synthesis of Blechert-type catalysts 19 and 20.
Table 2: RCM of N,N-diallyltoluenesulfonamide (21) with ruthenium catalysts.
catalyst (mol %) solvent t (h) T (°C) conv. (%) reference
G-II (5)
G-II (5)
G-II (3)
G-II (3)
G-II (3)
9 (3)
9 (3)
9 (3)
HG-II (3)
HG-II (1)
acetone/H2O 2:1
THF/H2O 4:1
MeOH/H2O 3:1
MeOH/H2O 1:3
DMF/H2O 1:3
MeOH/H2O 3:1
MeOH/H2O 1:3
DMF/H2O 1:3
acetone/H2O 2:1
DME/H2O 2:1
24
24
12
12
12
12
12
12
2
24
rt
rt
22
22
22
22
22
22
rt
rt
>95
3
29
77
82
87
94
94
>95
95
[35]
[35]
[34]
[34]
[34]
[34]
[34]
[34]
[35]
[35]
Figure 2: Chemical structure and components of amphiphilic molecule PTS and derivatives.
MeOH/H2O 1:3 and 29% conversion in MeOH/H2O 3:1). The
drastic loss of activity can be traced back to the better activity
of G-II under aqueous-emulsion conditions and the poor solu-
bility of G-II in MeOH. These results suggest how important
the role of the hydrophobic effect is on the catalytic activity of
the reaction. In fact, catalyst and substrate are encapsulated into
emulsion droplets formed in the reaction media above the
aqueous layer, making the reaction proceed “on water” [21,22].
The introduction of amphiphilic molecules for aqueous micellar
catalysis allows metathesis to proceed efficiently “in water”
[36]. Lipshutz and co-workers generalized the application of a
three-component non-ionic surfactant for numerous reactions
in water, including olefin metathesis [37-39]. The surfactant,
PTS, incorporates α-tocopherol, sebacic acid and PEG moieties
as part of its structure, resulting in a non-ionic amphiphile
(Figure 2).
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Scheme 6: RCM of selected substrates in the presence of the surfactant PTS. Conditionsa: The reaction was carried out at 60 °C for 24 hours.
In water, PTS forms nanomicelles which contribute to the solu-
bilization of water-insoluble substrates and catalysts, thus con-
tributing significantly to improve olefin metathesis yields. The
positive effect of this strategy was demonstrated by Lipshutz
and co-workers for RCM and for CM reactions [40,41].
Scheme 6 displays the RCM of selected substrates with G-II as
catalyst in the presence of PTS as surfactant. The work of
Lipshutz and co-workers is extensively reported elsewhere
[21,33,42,43].
Catalyst encapsulation is a recent example of “in water” metath-
esis with a heterogenous catalytic system. Pauly et al. used algi-
nate beads as a matrix to encapsulate the G-II catalyst for the
RCM of substrate 31 and 33 (Scheme 7) [44]. Alginate amide
beads perform best in neat water as they facilitate the diffusion
of hydrophobic substrates through the beads. However, the
reaction rates are very low compared to the non-encapsulated
catalyst G-II. The main advantage of the catalyst encapsulation
is the catalyst recycling, as the alginate beads can be reused up
to 10 times, retaining about 80% of activity.
Catalysts bearing quaternary ammonium
tags
Classical metathesis catalysts such as G-II and HG-II are
among the most active, stable and versatile ruthenium com-
plexes. Despite their high activity and remarkable stability, they
are sparingly soluble in neat water, thus challenging their use as
homogeneous catalysts in pure water. To overcome this chal-
lenge, a small amount of organic co-solvent (or surfactant) is
frequently used.
The removal of residual ruthenium traces is a crucial step
for most industrial applications [45-50]. Indeed, the purifica-
tion of products from metathesis reaction mixtures often
requires multiple tedious steps, primarily because metal
complexes’ impurities in the final product may cause isomeriza-
tion or decomposition of the products and may be toxic.
The latter is a very critical issue for the pharmaceutical
industry, as the amount of ruthenium in APIs (active pharma-
ceutical ingredients) may not exceed 100 µg/day for drugs
administered per os (oral administration) and 1 µg/day by
inhalation [51].
Some of the difficulties highlighted above can be overcome by
the incorporation of quaternary ammonium tags, which simplify
product purification as well as olefin metathesis in pure water
[52,53].
Grubbs and co-workers were the first to introduce water-soluble
catalysts which displayed metathesis activity in aqueous media
[54]. In 1996, Grubbs et al. reported that complexes 1 and 2 cat-
alyze the living opening polymerization of norbornene deriva-
tives 35 and 36 in neat water. Interestingly, the presence of a
Brønsted acid led to the protonation of one phosphine ligand
rather than reacting with the ruthenium alkylidene moiety.
Scavenging of the trialkylphosphine moiety resulted in a more
active complex capable of initiating the ROMP of 2,3-difunc-
tionalized norbornadienes and 7-oxo analogues (Scheme 8).
However, catalysts 1 and 2 are unstable in water and their use is
limited to ROMP. Polyethylene glycol (PEG)-tagged catalysts
(10 and 11, Figure 1c) showed significantly improved RCM ac-
tivities in water, but they tend to form aggregates in water due
to their high molecular weight (ca. 5,000 g·mol−1) [55]. A few
years later, Grubbs and co-workers reported the use of NHC
complexes containing quaternary ammonium tags [56].
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Scheme 7: RCM reactions of substrates 31 and 33 with the encapsulated G-II catalyst.
Scheme 8: Living ROMP of norbornene derivatives 35 and 36 with
phosphine-based catalysts bearing quaternary ammonium tags 1 and
2.
The catalysts 3 and 4 were obtained by the reactions of G-II
and the asymmetric Boc-protected derivative 39 with
2-isopropyloxystyrene derivatives 41 and 42 (Scheme 9). Cata-
lysts 3 and 4 showed modest activities in the ROMP of sub-
strate 35.
In 2006, Grela and co-workers reported the synthesis of the me-
tathesis catalyst 5 also bearing a quaternary ammonium tag
[57]. Following their previous studies highlighting the benefi-
cial effect of an electron-withdrawing group (EWG) on the
benzylidene moiety, such as NO2 [58], they proposed an “elec-
tron-donating to electron-withdrawing activity switch”,
consisting of an in situ formation of quaternary ammonium salts
by treatment with Brønsted acids (Scheme 10). Several metath-
esis reactions were performed in methanol/water mixtures with
EWG-substituted catalyst 5.
The “in situ” strategy was successfully applied to the prepara-
tion of catalysts 47, 48 and 49 by Skowerski et al. [59]. Treat-
ment of the free bases 44, 45 and 46 with methyl chloride
(MeCl) yielded the corresponding ammonium quaternized
groups (Table 3).
Beilstein J. Org. Chem. 2019, 15, 445–468.
452
Scheme 9: Synthesis of water-soluble catalysts 3 and 4 bearing quaternary ammonium tags.
Scheme 10: In situ formation of catalyst 5 bearing a quaternary ammonium group.
In a recent publication, catalyst 9 was used for an aqueous
living ring-opening metathesis polymerization-induced self-
assembly (ROMPISA). The authors demonstrated the possibili-
ty of performing living ROMP in water selecting a quaternary
ammonium-based phenyl norbornene carboximide as core-
forming monomer [60]. This polymer is currently being investi-
gated for possible biomedical applications.
Table 4 summarizes the activities of the different ammonium-
tagged catalysts discussed above with several water-soluble
substrates. Catalysts 3 and 4 showed modest to excellent activi-
ties in the RCM of N,N-diallylated substrate 50 (respectively
36% and >95% yield with 3 and 4) and substrate 54 (>95%
yield with both catalysts). There is no obvious explanation why
the RCM of 52 does not occur under identical conditions. Cata-
lysts 9, 47 and 48 display good activities for the ring-closing of
substrates 54 and 56, for the self-metathesis of allyl alcohol (59)
and the cis–trans isomerization of cis-butenedienol (Z-58).
Metathesis catalysts bearing quaternary ammonium groups
provide an attractive alternative to classical ruthenium catalysts.
Although they do not represent a great improvement in terms of
catalytic activity, they significantly improve the water solu-
bility and facilitate the removal of ruthenium residues from
reaction mixtures [52,59]. The majority of such ruthenium com-
plexes can easily be removed, especially for the metathesis of
water-insoluble substrates, as demonstrated by Grela and
co-workers for the RCM of diallylmalonate 31 in DCM
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Table 3: The “in situ” formation of quaternary ammonium-tagged catalysts.
precursor R R1 catalyst R2 R3
44 47
45 H 48 H
46 iPr 49 iPr
Table 4: Aqueous metathesis of selected substrates with water-soluble catalysts bearing quaternary ammonium groups.
substrate product cat. (mol %) T (°C) t (h) yield % (E:Z)
50
51
3 (5)
4 (5)
rt
rt
4
24
36
>95
52
53
3 (5)
4 (5)
rt
rt
24
24
<5
<5
54
55
3 (5)
4 (5)
9 (5)
47 (5)
48 (5)
rt
rt
rt
rt
rt
12
24
2.5
2.5
3.5
>95
>95
96
88
49
56 57
9 (5)
47 (5)
48 (5)
rt
rt
rt
5
5
5
46
41
62
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Table 4: Aqueous metathesis of selected substrates with water-soluble catalysts bearing quaternary ammonium groups. (continued)
Z-58
E-58
3 (5)
4 (5)
9 (0.5)
47 (0.5)
48 (0.5)
30
30
rt
rt
rt
2
24
0.16
0.13
1.1
94
92
94
94
71
59
E/Z 58
3 (5)
4 (5)
9 (5)
47 (5)
48 (5)
45
45
rt
rt
rt
6
24
24
24
24
69
82
77 (16.7:1)
38 (12.5:1)
74 (16.7:1)
Scheme 11: Catalyst recycling of an ammonium-bearing catalyst.
(Scheme 11). Upon reaction completion, the catalyst
is extracted from the organic reaction mixture with D2O
and (re)-used for the isomerization of cis-butenediol Z-58 in
water.
Recently the removal of a water-soluble catalyst from reaction
mixtures was also achieved with catalyst 12 (Figure 1c) through
host–guest interactions [61]. Chung and co-workers used a
PEG-tethered adamantyl ligand for various metathesis reac-
tions in water and DCM [62]. The authors showed that the cata-
lyst can be easily removed by generating a host–guest complex
between silica-grafted β-cyclodextrin and the adamantyl group
of catalyst 12. A simple filtration of the crude mixture through a
cotton plug after RCM of substrate 54 yields the purified prod-
uct with 53 ppm of residual ruthenium (Scheme 12).
Metathesis with artificial metalloenzymes
Directed evolution allows an iterative improvement by succes-
sive rounds of mutation and screening the performances of
genetically-encoded enzymes. Hypothesizing that this tool may
be applicable to the optimization of artificial metalloenzymes
(ArMs) for olefin metathesis, a new-to-nature bioorthogonal
reaction might be introduced in a biological system. ArMs
result from the incorporation of a catalytically active organome-
tallic moiety within a protein scaffold. Such biohybrid catalysts
enable a chemogenetic optimization of their catalytic perfor-
mances. As olefin metathesis is bioorthogonal, it offers attrac-
tive features for the manipulation of biological systems.
Comprehensive reviews on ArMs can be found elsewhere
[63,64]. Several artificial metalloenzymes able to perform me-
tathesis, coined artificial metathases, have been reported since
2011. The artificial metathases rely on different strategies to
anchor the organometallic moiety to the protein scaffold and
include supramolecular, dative, as well as covalent anchoring.
Ward and co-workers reported the first artificial metathase
based on the biotin–(strept)avidin technology in 2011 [65], thus
expanding the set of reported reactions with this class of ArMs
[66]. It is well known that the biotin–(strept)avidin couple pos-
sesses one of the highest non-covalent binding affinities
(Kd = 10−12–10−15 M). This exceptional affinity warrants the
ArM remaining assembled throughout catalysis. Biotinylated
HG-type catalysts anchored within (strept)avidin through supra-
molecular interactions were tested in the RCM of N,N-diallyl-
toluenesulfonamide (21) in aqueous media, achieving encour-
aging results at pH 4 and in the presence of MgCl2 [65]. The
chemical optimization of the organometallic moiety revealed
catalyst 60, which was combined with streptavidin (Sav) to
afford ArM 1 (Scheme 13). Ward and co-workers reported
another artificial metathase based on the dative anchoring of a
biotinylated HG-type catalyst to human carbonic anhydrase II
(hCAII) in 2015 [67]. The active site of hCAII contains Zn2+
which is coordinated to three histidines. Catalyst 61 contains an
arylsulfonamide moiety that coordinates the metal with high
affinity (Kd = 205 nM), affording ArM 2 (Scheme 13).
From the different organometallic moieties tested, the catalyst
containing 2,6-diisopropylphenyl groups on the NHC ligand
afforded the highest activity for the aqueous RCM of N,N-dial-
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Scheme 12: Removal of the water-soluble catalyst 12 through host–guest interaction with silica-gel-supported β-cyclodextrin.
Scheme 13: Selection of artificial metathases reported by Ward and co-workers (ArM 1 based on biotin–(strept)avidin technology and ArM 2 based
on dative anchoring to hCAII).
Beilstein J. Org. Chem. 2019, 15, 445–468.
456
Figure 3: In vivo metathesis with an artificial metalloenzyme based on the biotin–streptavidin technology.
lyltosylamine (21). Metathase ArM 2 performed best in phos-
phate buffer at pH 5.0, yielding 85% of product 22 (Table 5). A
substitution of lysine with histidine at position 198 (Table 5,
entries 8 and 9) did not improve the catalytic efficiency of ArM
2 at pH 7.0.
Jeschek et al. subsequently evolved ArM 1 in vivo by directed
evolution of an artificial metathase [68]. Tethering an OmpA
leader sequence to the N-terminus of streptavidin (Sav) allowed
the secretion and assembly of functional tetrameric Sav in the
periplasm of E. coli. The passive diffusion of the biotinylated
Hoveyda–Grubbs catalyst 60 through the outer membrane of
E. coli containing Sav in its periplasm then affords the artificial
metathase ArM 1. Upon addition of the umbelliferone precur-
sor 62, RCM reaction occurs in AcONa/AcOH buffer (pH 4.0)
in the presence of 0.5 M MgCl2. The formed umbelliferone (63)
can be detected by fluorescence (Figure 3).
The fifth generation Sav-mutant resulting from directed
evolution (Sav_mut5*) displayed a cell-specific activity
Table 5: Selected RCM reaction with hCAII-based artificial metathase
ArM 2.
entrya hCAIIb MCln (mol/L) pH TON
1
2
3
4
5
6
7
8
9
–
WT
–
–
WT
–
WT
L198H
L198H
MgCl2 (0.1)
MgCl2 (0.1)
–
MgCl2 (0.5)
MgCl2 (0.5)
NaCl (0.154)
NaCl (0.154)
NaCl (0.154)
–
6.0
6.0
7.0
5.0
5.0
7.0
7.0
7.0
7.0
48 ± 0.8
45 ± 2.0
23 ± 2.1
85 ± 1.0
78 ± 2.5
32 ± 2.0
21 ± 1.8
28 ± 0.6
22 ± 0.1
aReaction conditions: [21]: 1 mM, [61]: 10 μM, [hCA II]: 12 μM,
Vtot: 200 μL (DMSO 10%), 37 °C. Reactions carried out in triplicate.
bWT = wild-type.
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Table 6: Selected RCM results obtained with artificial metathase ArM 1 using purified Sav samples.
entrya substrate catalyst (%) proteinb TON
1
62
60 – 1.1
2
62
60 Sav 1.7
3
62
60 Sav_mut5* 4.4
4
64
60 – 180 ± 4c
5
64
60 Sav 430 ± 3c
6
64
60 Sav_mut5* 650 ± 35c
7d
65
60 – 30 ± 1
8d
65
60 Sav 52 ± 2
9d
65
60 Sav_mut5* 90 ± 3
aReaction conditions: 100 mM acetate buffer, 0.5 M MgCl2, pH 3.6, [catalyst] = 50 µM, 16 h at 37 °C and 200 rpm. bSav_mut5* = Sav V47A/N49K/
T114Q/A119G/K121R. cTON determined by 1H NMR. d[Substrate] = 20 mM; TON determined by UPLC–MS analysis.
5.4 ± 1.2 times higher than the wild-type enzyme. Table 6
summarizes the different RCM reactions tested using purified
ArM 1 in aqueous buffer at 37 °C [68,69].
Matsuo et al. used α-chymotrypsin as protein scaffold to
assemble an artificial metathase by covalent anchoring [70].
α-Chymotrypsin is a serine protease that recognizes hydro-
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Scheme 14: Artificial metathase based on covalent anchoring approach. α-Chymotrypsin interacts with catalyst 66 through supramolecular interac-
tions followed by covalent nucleophilic attack to afford ArM 3.
phobic residues in one of its clefts. A modified HG-type cata-
lyst (66) contains an L-phenyl chloromethyl ketone moiety that
acts as inhibitor and is first recognized by supramolecular
anchoring and then covalently attaches upon nucleophilic attack
at the chloromethyl moiety by the imidazole of His57, to afford
the artificial metathase ArM 3 (Scheme 14).
Matsuo et al. tested the RCM of three different substrates with
the protein-free catalyst 66 as well as ArM 3 (Table 7). No
RCM occurred with substrate 52 (<2 TON) with catalyst 66,
while the RCM of 67 reached 20 and 14 TON, respectively,
with ArM 3 and catalyst 66. However, ArM 3 decreased the
RCM activity of 21 to 4 TON compared to 20 TON with cata-
lyst 66.
In 2011, Hilvert and co-workers reported an ArM based on the
covalent anchoring of a metathesis catalyst to a small heat
shock protein from M. Jannaschii (MjHSP) [71]. The authors
reported a HG-II-type catalyst modified on its NHC backbone
with an α-bromoacetyl unit (68) that is reacted with the unique
cysteine of the modified MjHSP variant (G41C) to afford ArM
4 (Scheme 15).
The hybrid catalyst ArM 4 was then tested for the aqueous
RCM of substrate 21. In a H2O/t-BuOH mixture, the catalytic
efficiency of ArM 4 markedly increases upon lowering the pH
(Table 8, entry 6), although under the same conditions, the free
catalyst 68 performs better (Table 8, entry 3).
Cavity-size engineered ArMs are the first example of biohybrid
catalysts able to catalyze all three main olefin metathesis reac-
tions (RCM, ROMP and CM) [72]. Schwaneberg and Okuda
Table 7: RCM activities of catalyst 66 and ArM 3 with substrates 67,
52 and 21.
entry substrate catalyst TON
1
67
ArM 3 20
2
67
66 14
3
52
ArM 3 N.D.
4
52
66 <2
5
21
ArM 3 4
6
21
66 20
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Scheme 15: Assembling an artificial metathase (ArM 4) based on the small heat shock protein from M. Jannaschii (MjHSP). The protein structure is
based on the atomic coordinates in PDB entry 1SHS.
Table 8: RCM of N,N-diallyltoluenesulfonamide (21) with ArM 4.
entry catalyst (mol %) buffer pH TON
1
2
3
4
5
6
68 (2)
68 (2)
68 (2)
ArM 4 (4)
ArM 4 (4)
ArM 4 (4)
50 mM phosphate
50 mM MES
10 mM HCl
50 mM phosphate
50 mM MES
10 mM HCl
7.0
3.9
2.0
7.0
3.9
2.0
2 ± 0.2
16 ± 0.4
33 ± 0.5
3 ± 0.1
12 ± 1.5
25 ± 2.1
engineered the cavity size of the β-barrel protein nitrobindin
(variant 4, NB4) to accommodate HG-type catalysts. The
authors followed a similar approach developed earlier with a
variant of the β-barrel protein FhuA [73,74]. To do so, the
authors duplicated multiple β-barrel strands to enlarge the
cavity of the protein. HG-type catalysts bearing a maleimide
moiety with different spacer lengths (69–71) were covalently
anchored to a cysteine of the expanded nitrobindin variant
(NB4exp). The coupling reaction in aqueous buffer at pH 7.5
finally affords ArM 5, ArM 6 and ArM 7, respectively
(Scheme 16).
The obtained hybrid catalysts were tested for the RCM with
substrates 21 and 64 (Table 9). Overall, ArM 6 and ArM 7 are
comparable and perform best in both reactions with 35%
conversion of substrate 21 and quantitative conversion of
substrate 64. The water-soluble catalyst 9 was compared
to the hybrid catalysts, displaying a higher TON in the RCM of
21 (Table 9, entry 4). Interestingly, the activity of catalyst 9
is inhibited in the presence of NB4exp (Table 9, entries 5 and
10).
In the ROMP of the norbornene derivative 13, ArM 6 and ArM
7 performed best, outperforming catalyst 9. A near ten-fold
increase is observed for ArM 6 (Table 10, entry 2).
In the cross metathesis of terminal olefins 73, 74, and 75, with
the commercial catalyst 9 conversions of 79%, 98% and 94%,
respectively, were achieved. As in the RCM, the combination
with NB4exp did not give any conversion (Table 11, entry 5).
All three ArMs converted the three substrates with good yields
of products 76, 77 and 78. ArM 6 performed the best, affording
quantitative conversion for all three substrates (Table 11, entries
2, 7 and 12).
Gebbink and co-workers anchored the HG-type catalyst 79 to
cutinase, a serine hydrolase [75]. The phosphonate ester moiety
acts as a suicide inhibitor forming an irreversible covalent bond
to a serine residue present in the active site of the enzyme.
Assembly of ArM 8 occurs at pH 5 (Scheme 17). The activity
of the artificial metalloenzyme was tested with the benchmark
RCM substrate 21, yielding 84% of product 22 in acetate buffer
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Scheme 16: Artificial metathases based on cavity-size engineered β-barrel protein nitrobindin (NB4exp). The HG-type catalysts 69, 70 and 71 are lo-
cated inside nitrobindin to afford ArM 5, ArM 6 and ArM 7.
Table 9: Selected RCM results of N,N-diallyltoluenesulfonamide (21) and diol 64.
entry catalyst substrate conversion (%) = TON
1 ArM 5 21 16
2 ArM 6 21 35
3 ArM 7 21 35
4 9 21 41
5 9 + NB4exp 21 0
6 ArM 5 64 45
7 ArM 6 64 100
8 ArM 7 64 100
9 9 64 100
10 9 + NB4exp 64 0
Table 10: ROMP of 7-oxonorbornene derivative 13 with β-barrel engineered artificial metalloenzymes.a
entry catalyst conversionb (%) TON PDIc
1 ArM 5 25 3000 1.29
2 ArM 6 81 10000 1.21
3 ArM 7 75 9300 1.29
4 9 16 1700 N.D.
a[13] = 0.2 M. bDetermined by 1H NMR spectroscopy. cPDI = polydispersity index.
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Scheme 17: Artificial metathase based on cutinase (ArM 8) and resulting metathesis activities.
Table 11: Selected CM results with cavity-size engineered ArMs.
entrya catalyst substrate conversionb (%) TON
1 ArM 5 73 >99c 100
2 ArM 6 73 >99c 100
3 ArM 7 73 69c 69
4 9 73 79c 79
5 9 + NB4exp 73, 74, 75 0 0
6 ArM 5 74 45c 45
7 ArM 6 74 >99c 100
8 ArM 7 74 >99c 100
9 9 74 98d 98
10 ArM 5 75 40d 40
11 ArM 6 75 >99d 100
12 ArM 7 75 >99d 100
13 9 75 94d 94
a[Substrate] = 0.05 M. bConversions determined by 1H NMR. cE/Z =
20:1. dE/Z = 99:1.
at pH 5 (TON = 16.8). The same conditions were applied to the
self-metathesis of substrate 80, affording a quantitative conver-
sion (Scheme 17).
Olefin metathesis: applications in chemical
biology
Synthetic compounds are increasingly being used as chemical
tools to scrutinize and modulate biological systems [76]. Olefin
metathesis is a prime example of bioorthogonal reactions and
the ruthenium catalysts display good stability and chemoselec-
tivity. The first applications of olefin metathesis in chemical
biology were reported with “ill-defined” catalysts such as
RuCl3·H2O to synthesize insect pheromones by olefin metathe-
sis [77,78]. The development of well-defined ruthenium-based
catalysts increased the number of olefin metathesis applications
in chemical biology thanks to their tolerance against various
functional groups such as amides, alcohols and carboxylic
acids. However, one major hurdle for olefin metathesis in
chemical biology remains the necessity to perform catalysis
under mild conditions in buffered aqueous media.
The aqueous ROMP introduced by Grubbs and co-workers led
to several biological applications [79,80]. Kiessling and
co-workers were the first to use ROMP for the synthesis of bio-
logically active polymers and for the synthesis of multivalent
antigens to probe signaling pathways in vivo [81,82].
In 2008, Davis and co-workers performed site-selective protein
modification through aqueous CM [83], thus expanding the cat-
alytic repertoire of protein modification with transition-metal
catalysts [84-87]. A variant of subtilisin from Bacillus lentus
containing a single cysteine (SBL-S156C) was modified by
direct allylation to install an allyl-sulfide on the surface of the
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Scheme 18: Site-specific modification of proteins via aqueous cross-metathesis. The protein structure is based on the atomic coordinates in PDB
entry 1NDQ.
Scheme 19: a) Allyl homocysteine (Ahc)-modified proteins as CM substrates. b) Incorporation of Ahc in the Fc portion of IgG in human cells
(HEK 293T) and CM reaction with 84.
protein. Cross metathesis of the modified protein 82 with allyl
alcohol gave the CM product with over 90% conversion
(Scheme 18).
To achieve this challenging reaction, 200 equivalents (equiv) of
HG-II catalyst were employed in a reaction mixture containing
0.01 mM 82. Remakably, no conversion was observed in the
absence of MgCl2, which prevents the non-productive binding
of the amino acid side chains to ruthenium. The authors sug-
gested that the positive effect of allyl sulfides may be due to the
coordination of the sulfur atom to the ruthenium center,
favoring the formation of the metallacyclobutane intermediate.
The modest activities of butenyl and pentenyl sulfides were
rationalized by the formation of five and six-membered ring
chelates. The aqueous CM with allyl sulfides was also exploited
by Hunter et al. for the generation of a metathesis-based
dynamic combinatorial library [88].
The work carried out by Davis and co-workers led to the meta-
bolic incorporation of unnatural amino acids (uAAs) bearing a
terminal alkene as CM substrates for protein modification [89].
The authors investigated the possibility to incorporate methio-
nine (Met) analogues in a Met-auxotrophic strain of E. coli
(B834DE3). Allyl-homocysteine (Ahc) resulted in the only
uAA successfully incorporated into 6 different proteins, namely
Histone H3 (H3-Ahc120), Np276 (Np276-Ahc61), SsβG
(SsβG-Ahc49), SarZ (SarZ-Ahc4-Ahc43), Qβ (Qβ-Ahc16),
and Ubq (Ubq-Ahc1). The modified proteins were tested for
cross metathesis with allyl alcohol or with a fluorescein deriva-
tive (Scheme 19a).
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Table 12: Scope of RCM reactions using DNA-tethered substrates.a
entry substrate product conversion (%)
1
85
86
50
2
87
88
85
3
89 90
65
4
91 92
65
To further advance the chemical tagging through cross metathe-
sis, genetic incorporation of Ahc was performed in human cells
(HEK 293T) for the modification of the Fc region of IgG (IgG-
Fc-Ahc32, Scheme 19b). An olefin-bearing biotin 84 was
selected as olefinic partner for the CM reaction with the modi-
fied antibody, yielding IgG-Fc-Ahc32-biotin (Scheme 19b).
The conjugated protein can be selectively pulled-down with
avidin beads and analyzed by tandem MS after tryptic digestion.
This strategy suggests that CM reactions can be integrated in
the toolbox of chemical proteomics.
Recently, following a similar strategy, Lu et al. reported
on-DNA RCM and CM, an application potentially useful to
generate DNA-encoded libraries for hit identification and target
validation [90]. Substrates appended to oligonucleotides
undergo Ru-promoted RCM and CM when the G-III catalyst is
used under heterogeneous conditions (water/tert-butanol 3:2)
with a large excess of Mg2+. Also in this case, the role of Mg2+
is to protect the oligonucleotide from Ru-induced decomposi-
tion by binding to the phosphate backbone. Table 12 summa-
rizes the activities of 7 different DNA-tethered substrates for
RCM. Good conversions were achieved in water mixtures (40%
t-BuOH) at room temperature after 1 hour of reaction. Howev-
er, these reactions are not catalytic as they require 150 equiva-
lents of the G-III catalyst.
The same conditions were tested for the cross metathesis of the
allyl-sulfide 99 with allyl alcohol, yielding 50% of product 100
in aqueous mixture (40% t-BuOH) in the presence of
4000 equiv of Mg2+ (Scheme 20).
In another recent study, Touissant et al. described the synthesis
of two metathesis-based fluorescent probes suitable for the
detection of ethylene in live cells [91]. BODIPY fluorophores
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Table 12: Scope of RCM reactions using DNA-tethered substrates.a (continued)
5
93 94
50
6
95
96
55
7
97
98
50
a150 equiv G-III catalyst, [substrate] = 0.09 mM.
Scheme 20: On-DNA cross-metathesis reaction of allyl sulfide 99.
bearing the isopropyloxybenzylidene moiety (101 and 103)
reacted with the G-II catalyst to form the HG-II derivatives
102 and 104, respectively (Scheme 21).
The resulting compounds are Ru-based profluorescent probes
that become fluorescent in the presence of ethylene, thus
leading to the release of 101 from the Ru-catalyst (Scheme 22).
Live cell experiments with Chlamydomonas reinhardtii suggest
that 20 µM of probe 102 in PBS buffer are sufficient to turn
fluorescence on in cells flushed with exogenous ethylene or
ethylene gas derived from ripe fruit (e.g., banana or mango).
Control experiments reveal however a steady increase in fluo-
rescence in the absence of ethylene, suggesting that further opti-
mization of the probes is required. As ethylene plays an impor-
tant role as a plant hormone, metathesis-based probes might
have interesting applications in plant biology.
Olefin metathesis is also used to cross-link peptide fragments.
This technology is known as peptide stapling [92]. Blackwell et
al. engineered the first stapled peptide in 1998 by introducing
two non-natural amino acids bearing a terminal alkene in a
peptide sequence (e.g., 105, 106) [93]. The cross-linking of the
two amino acids by metathesis results in a more rigid and stabi-
lized alpha helix (products 107 and 108, Scheme 23).
Although the reaction cannot be classified as aqueous metathe-
sis (the reaction is carried out in CHCl3 and the peptide remains
attached to the solid phase), this technology has been exploited
to disrupt protein–protein interactions (PPIs) in cancer cells [94-
96]. Aileron Therapeutics recently launched a stapled peptide
platform aiming at developing molecules like ALRN-6924, a
stapled peptide that interacts with p53 inhibitors MDMX and
MDM4. The drug candidate is currently being evaluated in clin-
ical trials for different types of cancer [97].
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Scheme 21: Preparation of BODIPY-containing profluorescent probes 102 and 104.
Scheme 22: Metathesis-based ethylene detection in live cells.
Scheme 23: First example of stapled peptides via olefin metathesis.
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Conclusion
Over the past 20 years, the number of applications of olefin me-
tathesis in water has dramatically increased. The field of me-
tathesis is continuously growing and scientists seek new oppor-
tunities to exploit this powerful C–C double-bond-forming reac-
tion in different fields of research. Several biological applica-
tions have emerged over the past 10 years as a result of the ex-
tensive efforts to establish biocompatible protocols. While
aqueous metathesis offers the advantage of performing cataly-
sis in a more sustainable medium, it still remains challenging to
achieve due to the detrimental effect of water. Despite this limi-
tation, olefin metathesis widely contributes to polymer chem-
istry, drug discovery and biocatalysis. Several technologies
relying on aqueous metathesis have been developed (e.g., pro-
tein modification, on-DNA metathesis, directed evolution of
artificial metalloenzymes, etc.) and are paving the way to future
interesting applications.
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